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Reversible phosphorylation plays a key role in numerous biological processes. Mass spectrometry-based
approaches are commonly used to analyze protein phosphorylation, but such analysis is challenging,
largely due to the low phosphorylation stoichiometry. Hence, a number of phosphopeptide enrichment
strategies have been developed, including metal oxide aﬃnity chromatography (MOAC). Here, we
describe a new material for performing MOAC that employs a magnetite-doped polydimethylsiloxane
(PDMS), that is suitable for the creation of microwell array and microﬂuidic systems to enable low
volume, high throughput analysis. Incubation time and sample loading were explored and optimized and
demonstrate that the embedded magnetite is able to enrich phosphopeptides. This substrate-based
approach is rapid, straightforward and suitable for simultaneously performing multiple, low volume
enrichments.Introduction
Reversible protein phosphorylation is one of the most common
and important protein post-translational modications.1 Anal-
ysis of phosphorylation is commonly performed by mass spec-
trometry (MS), but this is challenging, primarily due to the low
stoichiometry of phosphorylation in biological samples.2
Therefore, samples are typically enriched for phosphopeptides
prior to MS analysis.
A number of methods for phosphopeptide enrichment have
been described in the literature, the most widely used being
immobilized metal aﬃnity chromatography (IMAC) and metal
oxide aﬃnity chromatography (MOAC).3 In IMAC, phosphory-
lated species are retained through the formation of metal–
ligand complexes, commonly chelated metal ions (Fe3+, Ga3+,
Al3+, Zr4+). MOAC exploits the aﬃnity of metal oxide surfaces for
phosphate groups4 and appears to have fewer limitations than
IMAC.5 MOAC approaches have been growing rapidly, in
particular methods employing TiO2 sorbents,6,7 which gained
popularity following reports by Pinkse et al. and Kuroda et al. in
2004 (ref. 8 and 9) and by Larsen et al. in 2005.10 Since then a
number of TiO2 enrichment strategies have been reported,
including the use of TiO2 particles trapped in a polymeric
monolith by photopolymerisation,11,12 centrifugation-based
protocols using suspensions of TiO2 particles13,14 and thelogy, University of Glasgow, Glasgow, G12
iversity, Birmingham, B4 7ET, UK
sity of Glasgow, Glasgow, G12 8LT, UK.
tion (ESI) available. See DOI:development of capillaries coated with thin TiO2 lms by liquid
phase deposition.15,16
A number of other metal oxides have also been successfully
employed for phosphopeptide enrichment, including ZrO2,17
Fe3O4 (ref. 18 and 19) and Al2O3.20,21 For phosphopeptide anal-
ysis by MALDI-MS, several reports have described on-target
approaches to enrichment.22–25 The implementation of phos-
phopeptide enrichment in a lab-on-a-chip (LOC) format26 has
many potential advantages including low sample volume
requirements, the potential both to multiplex parallel analysis
streams and integrate several sample preparation stages in a
single system,27–31 decreased analysis times, increased experi-
mental throughput and minimal sample handling.
However, there have been few reports describing LOC
phosphopeptide enrichment strategies. A commercial micro-
uidic HPLC-chip that incorporates a TiO2 bead bed is currently
available from Agilent (Phosphochip, Agilent Technologies).32,33
A microfabricated polymeric device whose internal microuidic
channels were coated with TiO2–ZrO2 by liquid phase deposi-
tion34 and an acoustophoresis device for eﬃcient on-chip
washing of TiO2-coated beads35 have been reported. The former
was successfully employed for phosphopeptide enrichment, as
demonstrated by the enrichment of the phosphopeptides from
a b-casein tryptic digest, but the fabrication processes were
complex and time consuming. In the latter, only the washing
stages were carried out on-chip. An alternative simple, low-cost,
exible approach that is amenable to straightforward integra-
tion with existing LOC platforms would, therefore, be benecial
for phosphoproteomic analysis.
We have developed a new, simple, rapid approach to
generating a moldable MOAC sorbent for phosphopeptide
enrichment that is compatible with microuidic technologies.This journal is © The Royal Society of Chemistry 2014
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View Article OnlineIt uses a polydimethylsiloxane (PDMS) substrate doped with
magnetite (iron(II/III) oxide) particles, etched to create a highly
roughened surface that is primarily composed of magnetite.
Magnetite was chosen as the sorbent as it is compatible with the
chemical processes necessary for generation of the substrate
(polymerisation, curing and etching), and may oﬀer the poten-
tial for magnetic patterning of the substrate in future applica-
tions. The enrichment protocol is rapid, suitable for low sample
concentrations, and has no particle contamination issues. As
the magnetite-PDMS material can be formed into a variety of
congurations, for example into microwell arrays or micro-
uidic channels, using standard replica molding techniques,
this approach is highly amenable to automated, low-volume,
high throughput analysis. Moreover, the sorbent can be reused
by re-etching the surface.Material and methods
Materials
The PDMS employed was Sylgard® 184 Silicon Elastomer Kit
from Dow Corning (VWR, Leicestershire, UK). The magnetite
particles (iron(II, III) oxide powder, particle size < 5 mm) and all
chemicals were purchased from Sigma-Aldrich (Dorset, UK),
except for MALDI calibration standards (Peptide Calibration
Standards II, 700–4000 Da, Bruker Daltonics) and porcine
trypsin (Sequencing Grade Modied Trypsin, Promega).Preparation & characterisation of magnetite-PDMS substrates
Magnetite-PDMS substrates were prepared as follows. The
PDMS prepolymer and curing agent were rst mixed in a 10 : 1
ratio (w/w). Magnetite particles were then added, with a parti-
cle : PDMS ratio of either 1 : 1, 1 : 2 or 1 : 4 (w/w), and thor-
oughly mixed to create a homogenous suspension. To create an
array of wells with 96-well plate spacing, the PDMS mixture was
poured over an upturned, round-bottomed, 96-well plate
(Costar® cell culture plate, Corning®), around which a frame
constructed from glass microscope slides had previously been
bonded in order to contain the polymer mixture. For micros-
copy analysis, the PDMSmixture was cast over a polished silicon
wafer (Compart Technology, Peterborough). Aer degassing the
PDMS mixture by placing the mold inside a vacuum desiccator
and pumping down the chamber, the PDMS was cured in an
oven at 50 C overnight. The cured PDMS was then peeled oﬀ
the mold and placed in an oven at 95 C for a further 24 hours to
enhance PDMS crosslinking.36
To etch back the surface PDMS matrix and expose the
embedded particles, an etchant was prepared from a 75% (w/w)
aqueous solution of tetrabutylammonium uoride (TBAF),
which was diluted 1 : 10 with N-methylpyrrolidinone (NMP) to
form a 7.5% TBAF solution. The etchant was prepared imme-
diately prior to use. Substrates were immersed in the etchant
and gently agitated for 2 min. They were then rinsed twice with
NMP and twice with ethanol, prior to gently blow drying.
The magnetite-PDMS substrates were characterized by both
scanning electron (SEM) and atomic force (AFM) microscopies.
Prior to SEM analysis, using a Hitachi S4700 SEM with anThis journal is © The Royal Society of Chemistry 2014accelerating voltage of 10 kV and an emission current of 10 mA,
the samples were sputter-coated with a thin layer of gold–
palladium (approximately 10 nm). AFM characterization was
performed using a NanoWizard II Bio AFM (JPK Systems,
Berlin).
Tryptic digest of bovine b-casein
Tryptic digestion was carried out overnight at 37 C in 25 mM
ammonium bicarbonate, pH 7.8, using a protein : trypsin ratio
of 20 : 1. The digested casein was aliquoted and frozen at
20 C. Prior to enrichment, an aliquot of the digest was
evaporated to dryness in a SciQuip Christ freeze dryer and
resuspended by vortexing in an appropriate volume of loading
buﬀer (80 : 15 : 5) acetonitrile (ACN) : triuoroacetic acid
(TFA) : distilled water (dH2O). The samples were then claried
by centrifugation at 13 000 rpm for 30 s.
Preparation of HeLa cell lysate
Human cervical epithelial (HeLa) cells were cultured in T150
asks in DMEM media supplemented 10% fetal calf serum,
100 mg ml1 penicillin, 100 mg ml1 streptomycin at 37 C in a
humidied 5% CO2 atmosphere to 90% conuence. The cells
were then washed 3 times in ice-cold PBS and harvested by the
addition of 50 mM TRIS, 8 M urea, pH 7.3 including phospha-
tase inhibitors (cocktail 2 and 3, Sigma) and protease inhibitors
(Roche) and detached with a cell scraper. The cells were further
lysed by sonication using a microprobe at 100% output for 10 
10 seconds with 1 minute intervals. The resulting cell lysate was
centrifuged at 16 900g for 90 minutes at 4 C. The supernatant
was collected and the protein concentration was determined
using the Bradford method (Bradford M.M, 1976).
The HeLa cell lysate and a control sample of a-casein were
incubated with 15 ml of 0.5 M DTT for 30 minutes at 60 C and
then allowed to cool to room temperature and incubated with
40 ml of 0.5 M iodoacetamide at room temperature for 30
minutes. The proteins were precipitated with trichloroacetic
acid (TCA) (nal concentration 10%) and washed twice in ice-
cold acetone and then dried in a vacuum centrifuge. The dried
precipitates were resuspended in 50 ml of 50 mM TRIS, 8 M urea,
pH 8.3 and incubated for 30 minutes, then 400 ml of MilliQ
water was added to reduce the urea concentration to below 1 M.
Sequencing grade trypsin was added in a ratio of 1 : 40 (w/w,
trypsin–protein). The samples were allowed to digest O/N at
37 C and then acidied by the addition of 5% formic acid and
puried on a C18RP column (SepPak, Waters Corporation).
Phosphopeptide enrichment from b-casein
Before performing an enrichment, the PDMS substrates were
washed with methanol, 0.1 M ammonium hydroxide, dH2O and
then loading buﬀer. 100 ml of sample containing claried digest
from 5, 20, 50 or 100 ng of b-casein protein was added to each
well and le to incubate for 2, 5, 12 or 20 min. Aer pipetting oﬀ
the supernatant, the wells were washed twice with loading
buﬀer and once with 10 : 90 ACN : dH2O, with a 1 min incu-
bation per wash. The substrates were then le to dry in air for
5 min. A 15 min incubation with 150 ml 0.1 M ammoniumAnalyst, 2014, 139, 4974–4981 | 4975
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View Article Onlinehydroxide per well was used to elute the phosphopeptides. 4 ml
of 20% FA was added to each elution fraction collected to acidify
the solution for subsequent analysis and to stabilize the
phosphopeptides.
Phosphopeptide enrichment from HeLa lysates
Using the magnetite/PDMS substrate, digested HeLa cell lysate
or digested HeLa cell lysate spiked with digested bovine
a-casein (1 : 1 ratio) were added to substrate wells (1 mg protein
per well) and incubated and eluted as described above.
Enrichment using TiO2 was performed using the Pierce
Magnetic Phosphopeptide Enrichment Kit (Thermo Fisher,
Rockford, USA), following the manufacturers protocol using
5 mg of lysate per 2.5 ml of beads.
MALDI mass spectrometry analysis
Prior to mass spectrometry analysis, collected fractions were
dried to completion by freezer drying, before resuspending in 3
ml of a 20% dilution of saturated dihydroxybenzoic acid (DHB)
in 50% ACN, 0.1% TFA. 1.5 ml of each sample was spotted onto a
stainless steel MALDI target (MTP 384 target plate, Bruker
Daltonics), alongside peptide standard calibration spots.
Fractions were analysed using a Bruker Daltonics Ultraex III
MALDI TOF/TOF tandem time-of-ight mass spectrometer in
positive ion reectron mode. The laser spot size was set to
minimum (10 mm), the matrix suppression deection tom/z 690
and the detection range to m/z 700–3600. The laser power
intensity was optimized to give maximum sensitivity without
saturation for the fractions with the strongest signals and this
power intensity was then used for all spectra acquired. For each
spot, data was collected from 5000 shots red at numerous
points across the entire area. Biotools soware version 3.1
(Bruker Daltonics) was used to deconvolute the spectra
obtained using the SNAP algorithm (S/N threshold of 4, quality
factor threshold of 20) to produce a list of monoisotopic masses
with normalized intensities. Phosphopeptide enrichment was
quantied by comparing the measured intensities of ve
phosphopeptide peaks (m/z: 2061.83, 2432.05, 2962.42, 3042.39,
3122.35 Da) to the seven most common non-phosphopeptide
peaks (m/z: 742.45, 780.50, 830.45, 873.49, 1013.52, 2186.17,
2909.60 Da). A script was written in Matlab (Mathworks) to
extract the intensities of each of these peaks and to return a
value corresponding to the percentage of the summed phos-
phopeptide signal intensity relative to the total intensity of all
12 peaks. For each experimental condition, mean values from a
minimum of three replicates are reported, with error bars cor-
responding to one standard error.
Nano LC-MSMS analysis
The dried phosphopeptide enriched samples and an unen-
riched sample were resuspended in 2% acetonitrile (0.1% for-
mic acid) and analysed by LC-MSMS. Peptides were separated
and analysed using an Ultimate 3000 system (Dionex, Cam-
berley) and a 5600 TripleTOF (ABSciex, Warrington, UK)
controlled by Chromeleon Xpress and Analyst soware (1.5.1 or
TF, ABSciex, Warrington). The peptides were puried on a4976 | Analyst, 2014, 139, 4974–4981C18RP pre-column (C18 PepMapTM, 5 mm, 5 mm  0.3 mm i.d.
Dionex, Bellefonte, PA, USA) by washing for 4 min with 2%
aqueous acetonitrile (0.1% formic acid) at 30 mL min1. The
peptides were then separated on a C18 nano-HPLC column (C18
PepMapTM, 5 mm, 75 mm i.d. 150 mm, Dionex, Bellefonte, PA,
USA) using a gradient elution running from 2% to 45% aqueous
acetonitrile (0.1% formic acid) in 3 hours and a nal washing
step running from 45% to 90% aqueous acetonitrile (0.1% for-
mic acid) in 1 min. The system was then washed with 90%
aqueous acetonitrile (0.1% formic acid) for 5 min and the
equilibrated with 2% aqueous acetonitrile (0.1% formic acid).
High resolution TOF MS mode was used to collect scans in
positive mode from 350 to 1200 Da for 250 ms. MS/MS data was
collected using information-dependent acquisition (IDA) with
the following criteria: the 10 most intense ions with +2 to +5
charge states and a minimum of intensity of 200 counts-per-
second (cps) were chosen for analysis, using dynamic exclusion
for 20 s, 250 ms acquisition and a xed collision energy setting
of 50  5 V.Mascot analysis and extracted ion chromatogram (XIC)
generation
Peptides were identied using Mascot version 2.4.1. (Matrix
Science, London), selecting the xed modication of carbomi-
domethyl (C) and variable modications; deamidation, phos-
phoserine, phosphotyrosine, phosphotheonine and oxidized
methioine. In all cases the data was searched against the
Swissprot data base (v. SwissProt_2013_08) using Mammalia
taxonomy. Both the peptide and the fragment tolerance were set
at 0.1 Da, choosing +2, +3 and +4 charge states and allowing for
one missed cleave by trypsin. Phosphopeptides were manually
validated from raw data les and manual de novo sequencing
and XIC were generated using PeakView (ABSciex). using a 0.05
Da window, and where necessary Gaussian smoothed with a 5
point window and baseline subtracted with a 3 min window.Results and discussion
Characterization of Magnetite-PDMS substrates
The aim of this work was to develop a simple, moldable, exible,
rapidly produced MOAC sorbent for phosphopeptide enrich-
ment that is compatible withmicrouidic technologies and that
could also be employed within a conventional laboratory to
create microwell arrays. PDMS is the most ubiquitously used
material in the LOC eld, with a number of advantageous
characteristics,37 and was employed to create a composite metal
oxide–polymer for surface. A series of substrates was produced
using various particle : PDMS doping ratios to determine the
optimum doping level. Prepolymer mixtures with particle
loadings greater than 1 : 1 were too viscous for reliable casting
and so substrates with particle : PDMS ratios of 1 : 1, 1 : 2 and
1 : 4 were characterized. These mixtures can be used as normal
PDMS for replica molding, including casting over micro-
fabricated structures. The fabrication process and example of
such structures, which demonstrates that this composite PDMSThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinematerial can easily be incorporated into microuidic systems,
are shown in Fig. 1.
For characterization of the surface by SEM and AFM, the
magnetite-PDMS was cast over a polished silicon wafer to
produce a substrate with an initially smooth, level surface.
Following curing, the substrates were etched using a TBAF
solution,38 resulting in the removal of the surface PDMS to
expose the embedded magnetite particles (Fig. 2a). Increasing
the particle doping level increased the concentration of parti-
cles at the surface (Fig. 2a), with a 1 : 1 particle : PDMS ratio
producing a highly roughened surface that is predominantly
composed of magnetite particles. The rms surface roughness of
this substrate was measured by AFM to be 264  74 nm, with a
peak-valley height of 1.25  0.22 mm (both mean  standard
error, taken from the measurement of seven 5  5 mm regions
across the substrate). For all results reported below, a magnet-
ite : PDMS ratio of 1 : 1 was employed.Fig. 2 SEM and AFM characterization of magnetite-PDMS substrates.
(a) SEM images taken at 400 and 10 000 magniﬁcation of three
substrates with diﬀerent magnetite : PDMS ratios. (b) A typical AFM
image of 1 : 1 magnetite-PDMS substrate.Enrichment of phosphopeptides
To demonstrate that the fabrication procedure did not aﬀect the
phosphopeptide binding properties of the magnetite, and to
optimize the adsorption and elution conditions, enrichment of
a b-casein digest was used, which allowed comparison with
previous work.18,19 To enable rapid optimization of multiple
enrichment parameters, magnetite-PDMSmicrowell arrays with
a volume of approximately 100 ml were created using the
optimum 1 : 1 particle : PDMS doping ratio by casting the
magnetite-PDMS over the back of a 96-well cell culture plateFig. 1 Fabrication of magnetite-PDMS structures. (a–c) The fabrica-
tion process. PDMS prepolymer is mixed with magnetite particles and
cast over a suitable mold (a). After curing, the magnetite-PDMS is
peeled oﬀ (b) and the surface PDMS etched back (c) to expose the
embedded magnetite particles. (d and e) show an example of a
microﬂuidic channel (50 mm deep) fabricated from magnetite-PDMS
(1 : 1 particle : PDMS ratio). The mold used for casting this channel was
fabricated as previously described.29 The scale bar in photograph (d) is
3 mm. Micrograph (e) shows a magniﬁed region of the serpentine
channel packed with 50 mm diameter internal pillars, the scale bar is
100 mm. (f) A photograph of a 4  4 well array with 96-well plate
spacing (the centre–centre distance is 9 mm).
This journal is © The Royal Society of Chemistry 2014(Fig. 1f). Aer etching back the surface, phosphopeptide
enrichment of a tryptic digest of b-casein was carried out. The
enriched and unenriched fractions were analysed by MALDI-
TOF mass spectrometry and the results compared to those
obtained previously. Samples were loaded into the wells in an
acidic buﬀer to minimize the binding of non-phosphorylated
peptides and incubated for the required time. The wells were
then briey washed with buﬀers containing ACN, which lowers
the surface tension of these solutions allowing them to better
wet the surface, before bound phosphopeptides were eluted in
0.1 M ammonium hydroxide.
Eluted fractions were analyzed with MALDI-MS (sample
spectra in ESI Fig. S-1, peptide data in ESI Table 1†). Following
magnetite-PDMS enrichment, the strong signals from non-
phosphopeptide peaks are very signicantly reduced, and clear
signals from both phosphopeptides can be seen. The identity of
the phosphopeptides was conrmed by MSMS (data not
shown). This high level of enrichment is very similar to that
reported before for magnetite enrichment,18,19 demonstrating
that the procedure to generate the sorbent does not aﬀect its
binding properties. Higher ammonium hydroxide concentra-
tions in the elution buﬀer (0.4 M or 1 M) did not improve the
data. Adding 10% ACN to the eluent improved its surface
wetting properties but the enrichment results obtained were
poorer, with no phosphopeptides being clearly detected at the
same laser power (ESI Fig. S-2†). Magnetite is a fairly well
characterized substrate for phosphopeptide enrichment.18,19 AsAnalyst, 2014, 139, 4974–4981 | 4977
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View Article Onlinewith other iron-based enrichments substrates, it shows a
slightly diﬀerent bias in physiochemical properties of the
enriched peptides to the more commonly used TiO2
substrates,39 with a stronger enrichment of more acidic phos-
phopeptides, although it is still able to enrich a broad range of
phosphopeptides with high selectivity.Optimisation of adsorption and elution conditions
The eﬀect of both analyte concentration and incubation time
was assessed using b-casein peptides. To quantify the enrich-
ment levels, the normalized MALDI peak intensities were
extracted for seven non-phosphopeptide peaks and ve phos-
phopeptide peaks. The enrichment level was then expressed as
the percentage of the summed phosphopeptide intensities with
respect to the sum of the intensities of both phosphopeptide
and non-phosphopeptide peaks (%phospho, where 100%
signies the detection of only phosphopeptides). The %phospho
value obtained when analyzing a series of 50 ng samples of the
unenriched b-casein digest was 0.84%  0.21% (mean  SEM,
n¼17).
Sample loadings from 5 to 100 ng (corresponding to low
pmol to fmol quantities of sample) and incubation times from 2
to 20 min were tested. The mean %phospho values obtained are
reported in Fig. 3 (n$ 3 for each experimental condition). These
demonstrate that enrichment of the phosphopeptides is
maintained across these conditions, and is good even at lower
sample loadings and short incubation times. A 5 min sample
incubation produced high enrichment levels for all loading
conditions with good reproducibility (mean over all loadingsFig. 3 Variation in phosphopeptide enrichment levels with sample
loading and incubation time. A summary of themean %phospho values
obtained for diﬀerent sample loadings (the mass of b-casein protein
used to produce the clariﬁed digest samples) and sample incubation
times. A script was written in Matlab (Mathworks) to extract the
intensities of each of these peaks and to return a value corresponding
to the percentage of the summed phosphopeptide signal intensity
relative to the total intensity of all 12 peaks. The error bars correspond
to +/ one standard error (n $ 3).
4978 | Analyst, 2014, 139, 4974–4981was 96.3  3.1%, n ¼ 13). Lower sample loadings down to 5 ng
did not signicantly compromise enrichment, but higher
sample loadings (i.e. 100 ng) or extended incubation times (i.e.
20 min) reduced enrichment and increased sample to sample
variation. The use of the microwell array format was particularly
benecial for rapidly optimizing the enrichment protocol.
The optimum loading level and incubation time is likely to
vary for diﬀerent samples since it is important to get the correct
balance between phosphopeptide enrichment and non-specic
adsorption, which appears to increase with longer incubation
times or loading highly concentrated samples, possibly due to
diﬀerential kinetics of binding. The microwell array format
reported here is well suited to rapidly optimizing the enrich-
ment protocol, as several diﬀerent sample loadings or other
experimental conditions, each requiring only a low volume
sample, can be performed in parallel.
Reuse of substrate
One distinct advantage of this system is that following enrich-
ment themagnetite-PDMS substrates can readily be re-etched to
reveal a fresh surface, enabling a substrate to be re-used many
times. Four etching-enrichment cycles have been tested, each
fresh surface having successfully enriched phosphopeptides
with no discernible loss of aﬃnity, and many more cycles could
be performed as the magnetite particle concentration is
uniform throughout the substrate. One previously identied
drawback of PDMS is the potential for leaching of lowmolecular
weight (LMW) siloxanes, which could result in sample
contamination.40–43 Therefore, spectra obtained from four
separate elution fractions were extensively searched for signs of
LMW siloxane contamination (details in ESI Table 2†), over an
increased mass range (100–3600 m/z). However, no evidence of
contamination attributable to PDMS oligomers was found,
probably due to a combination of the extended 95 C bake
(which should enhance PDMS crosslinking), the high level of
magnetite particle doping (which results in a reduced PDMS
volume fraction) and the etching of the surface PDMS (which
creates a surface that is primarily composed of magnetite).
Enrichment from complex samples
To demonstrate the use of the substrate for a more complex
sample, phosphopeptides were enriched from an a-casein
spiked HeLa lysate to show the degree of enrichment, and from
a normal HeLa lysate for general phosphopeptide enrichment,
using the optimized procedure described above. It was found
that for the complex samples, the optimal sample loading per
well was higher, with 1 mg per well giving good results, but
phosphopeptides could be detected down to 100 ng of sample.
Samples were analyzed by LC-ESI-MSMS followed by generation
of extracted ion chromatograms (XIC) for relative quantication
for a number of phospho and non-phosphopeptides. As
described for the pure b-casein digest, the magnetite doped
substrate showed a high degree of enrichment of a-casein
phosphopeptides from the spiked lysate (details of peptides in
ESI Table S-3†), with only traces of the non-phosphopeptides
remaining (Fig. 4).This journal is © The Royal Society of Chemistry 2014
Fig. 4 Enrichment of a-casein phosphopeptides from a casein spiked
HeLa cell lysate. (a) XIC traces for unenriched control showing 4
phosphopeptides (P1–P4) and 4 non-phosphopeptides (N1–N4)
(details of peptides in ESI table S-3a†) and (b) sample enriched using
the magnetite-PDMS substrate showing XIC of the same peptides.
Peaks for non-phosphopeptides are very much reduced or absent.
Fig. 5 Enrichment of phosphopeptides from a HeLa cell lysate. XIC for
10 phosphopeptides from a HeLa cell lysate (P1–P10, details in ESI
Table S-3b†) using (a) our substrate and (b) a commercial TiO2 based
kit (Pierce), showing a similar enrichment, but with some diﬀering
aﬃnities between the two methods. (c) XIC for the same masses as (a)
and (b) but in an unenriched HeLa lysate; this shows peptides isobaric
to the phosphopeptides eluting at diﬀerent times to the phospho-
peptides, which are not seen in (a) and (b), and no traces of the
phosphopeptides, demonstrating the high levels of enrichment for
both methods.
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View Article OnlineTo demonstrate the use of the substrate for enrichment of
phosphopeptides from a more general sample, and to make a
comparison with enrichment using the most commonly used
metal oxide, TiO2, phosphopeptides were enriched from a HeLa
lysate using a commercial TiO2 based kit (Pierce Magnetic
Phosphopeptide Enrichment Kit) and our substrate. Enrich-
ment of phosphopeptides was seen in both cases. XIC were
generated for a number of phosphopeptides with a range of
physicochemical properties (ESI Table S-3b†) that were identi-
ed from a MASCOT search of the data, to demonstrate
enrichment and compare the two substrates. Fig. 5 shows the
XIC for 10 phosphopeptides using the magnetite doped PDMS
(Fig. 5a) and the commercial TiO2 kit (Fig. 5b). For comparison,
Fig. 5c shows the XIC generated at the same masses as the
phosphopeptides used to generate Fig. 5a and b from an
unenriched HeLa lysate. A number of isobaric, non-phosphor-
ylated peptides are picked up, and peaks corresponding to the
phosphopeptides cannot be seen, clearly demonstrating the
enrichment in Fig. 5a and b. There is, therefore, signicant
enrichment using both substrates, but as has been noted
before, there are some diﬀerences in enrichment eﬃciencies for
peptides with diﬀerent physicochemical properties between the
two diﬀerent sorbants. Diﬀerences in intensities between
Fig. 5a and b relate to the signicant diﬀerence in sorbentThis journal is © The Royal Society of Chemistry 2014surface areas between the two methods, resulting in lower
capacity for the magnetite embedded system than the large
volume of particulate TiO2 used in the commercial kit. However,
the magnetite doped PDMS appears to perform well, and the
processing of the substrate does not appear to have aﬀected its
ability to enrich phosphopeptides.Analyst, 2014, 139, 4974–4981 | 4979
Analyst Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
1 
Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
on
 2
4/
11
/2
01
4 
13
:5
6:
47
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineConclusions
A new magnetite-PDMS based material for performing phos-
phopeptide enrichment is reported. This uses a rapid and
straightforward protocol, with key enrichment parameters
having been optimised. Levels of phosphopeptide enrichment
similar to those seen previously for magnetite were obtained.
The principal benets of this composite polymeric material,
whose surface can be simply refreshed to enable reuse, are its
compatibility with LOC systems and the ability to simply
produce large-scale, low-volume microwell arrays for high
throughput analysis. The simple enrichment protocol, which
involves no particle suspensions (therebyminimizing the risk of
particle contamination) or centrifugation steps, and the bene-
ts of being able to re-etch the substrate, means that this
magnetite-PDMS provides a cheap, rapid and straightforward
approach for phosphopeptide enrichment that is amenable to
LOC methods, high throughput analysis and automation.Acknowledgements
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